General Neurology
Placebo and nocebo effects in neurologic disorders
Jun. 11, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Video-EEG images of an 8.5-year-old girl who was referred by a child psychologist following an assessment for educational problems and facial grimaces. At the age of 6 years, she started having eyelid jerks, but her parents believed that she was having tics. The sleep-awake video-EEG confirmed discharges and clinical phenomena on voluntary and on demand eye closure, which became worse during hyperventilation and intermittent photic stimulation. The photosensitivity range was 5 to 40 Hz. Note the girl’s attempts to avoid the clinical phenomena. Past and developmental histories were noncontributory. The response to sodium valproate monotherapy was complete and has remained so for the past 7 years. Although her school performance has shown some improvement, it has remained average. (Contributed by Athanasios Covanis MD PhD.)